USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Integra Biosciences AG

USPTO PatentsView assignee record - 26 granted patents across 11 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

RSS updates for this company

The verdict

According to USPTO PatentsView, Integra ranks #11,679 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 11 technology areas.

#11,679
of 49,997 US assignees by volume
Top 31%
by Innovation Score (42.2/100)
9.5
avg claims per patent
+56%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11679 · Foreign Corporation #11,679 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 26 grants
  • UPPER-Q #11,679/49,997
  • PHOTO-FINISH Ikeda Food Research
  • CPC-FOCUS B01L · 11 areas
  • INNOV-PAR 42.2/100
  • CLAIMS-PAR 9.5 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +56% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ikeda Food Research Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Integra’s 42.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Integra

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Integra's Innovation Score is 42.2/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Integra?

Each dot is one of Integra’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Integra’s own 9.5 claims/patent is at or below the 14.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Integra vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 25.92626.1 510152025 Granted patents (volume) Avg claims / patent Ikeda Food Research Co., Ltd. - 26, 10.46Ikeda Food Resear…Innovator Energy LLC. - 26, 19.5Innovator EnergyInstitut National DE Recherche EN Informatique ET EN Automatique (INRIA) - 26, 14.54Institut National…Imation Corp. - 26, 19.85ImationIntellikine LLC - 26, 14.54IntellikineInter-University Research Institute Corporation Research Organization of Information and Systems - 26, 13.85Inter-university…Interactive Intelligence Group, Inc. - 26, 23.69Interactive Intel…International Semiconductor Group - 26, 12.96International Sem…Integra Biosciences AG - 26, 9.54Integra Bioscienc…
Integra vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Integra's grants concentrate

Integra Biosciences AG is a focused PatentsView assignee: 11 CPC subclasses with 53.8% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2019. By volume, Integra sits between Ikeda Food Research Co., Ltd. and International Semiconductor Group.

Integra's three-year grant acceleration

Integra Biosciences AG shows 10 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Integra's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Integra holds 26 patents at rank #11,679, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Integra

By rank, the assignees closest to #11,679 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Integra's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Integra, neither rank-band nor same-CPC leaders (those blocks stay above). In B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), Integra ranks #129 of 1,325 assignees by patent count in that subclass.

Integra's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20162018201920212022202320242025 3
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Integra Biosciences AG patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 4 15.4%
2018 4 15.4%
2019 1 3.8%
2021 4 15.4%
2022 2 7.7%
2023 3 11.5%
2024 5 19.2%
2025partial year 3 11.5%

Which technologies does Integra Biosciences AG patent most?

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Integra Biosciences AG's patent record in context - here's where to go next.

  • Integra Biosciences AG's lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 53.8% of its portfolio - see every assignee active in that class. Explore B01L
  • Ranked #11,679 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Integra Biosciences AG against Ikeda Food Research Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 42.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.